MedTrace Logo

A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer

NCT01732380 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2012-11-22

No results posted yet for this study

Summary

The aim of this study was to compare raltitrexed/oxaliplatin plus radiotherapy versus radiotherapy in subjects with inoperable esophageal cancer.

Conditions

  • Inoperable Esophageal Cancer Stage I-III

Interventions

DRUG

Raltitrexed

DRUG

Oxaliplatin

RADIATION

Radiotherapy

Sponsors & Collaborators

  • The East Hospital of Lianyungang

    collaborator UNKNOWN

  • Donghai People's Hospital

    collaborator OTHER

  • People's Hospital of Ganyu

    collaborator OTHER

  • The First People's Hospital of Lianyungang

    lead OTHER

Principal Investigators

  • Xiaodong Jiang, Doctor · The First People's Hospital of Lianyungang

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01732380 on ClinicalTrials.gov